Skip to main content

Table 1 Eligibility criteria for patient risk groups that were screened for C. auris

From: Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

GroupDescriptionNotes
Group 1 (n = 92)recent hospitalization outside of Canadatime periods defining recent overseas hospitalization (0.5, 1, or 2 years) varied as per each hospital policy
Group 2 (n = 117)recent travel to the Indian subcontinent without hospitalizationtime periods defining recent travel (1 or 2 years) varied as per each hospital policy
Group 3 (n = 104)CPO colonized or infected inpatients or outpatients and consenting participants in a different prospective CPO cohort study 
Group 4 (n = 282)units that are associated with intensive antifungal usepatients identified by hospital census on a single day
Group 5 (n = 0)hospital contacts of a C. auris index casescreening as per each hospital policy